XPC-198

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameXPC-198
Drug Alias NameXPC-198
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSodium channel protein type VIII alpha subunit blockers
TargetsSodium channel protein type VIII alpha subunit
Therapy Area/IndicationsEpilepsy
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesXenon Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesXenon Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsEpilepsy

Other Information

ATC CodeN/A
Related LinksN/A